Henan Eye Hospital, Henan Eye Institute, Henan Provincial People's Hospital, Zhengzhou, 450003, People's Republic of China.
People's Hospital of Zhengzhou University, Zhengzhou, 450003, People's Republic of China.
Int J Nanomedicine. 2024 Jul 25;19:7605-7616. doi: 10.2147/IJN.S465965. eCollection 2024.
Corneal neovascularization (CNV) is a common eye disease that leads to blindness. New treatment strategies are urgently needed due to the limitations of current treatment methods.
We report the synthesis of peptide Nap-FFEEPCAIWF ( ) via chemical conjugation of Nap-FFEE ( ) to antiangiogenic peptide PCAIWF . self-assembled into a hydrogel ( ) composed of nanofibers, which enhanced the antiangiogenic function of the epitope.
We developed a novel peptide with an amphiphilic framework, , which could self-assemble into a supramolecular hydrogel with a well-ordered nanofiber structure. The nanofibers exhibited good biocompatibility with corneal epithelial cells, presenting a promising strategy to enhance the efficacy of free peptide-based drugs in the treatment of ocular vascular diseases, such as CNV and other angiogenesis-related diseases.
Nap-FFEEPCAIWF nanofibers provide an alternative approach to enhancing the therapeutic efficiency of free peptide-based drugs against ocular vascular diseases.
角膜新生血管(CNV)是一种常见的致盲眼病。由于目前治疗方法的局限性,迫切需要新的治疗策略。
我们通过将 Nap-FFEE( )化学偶联到抗血管生成肽 PCAIWF 上来合成肽 Nap-FFEEPCAIWF( )。 自组装成由纳米纤维组成的水凝胶( ),增强了表位的抗血管生成功能。
我们开发了一种具有两亲性框架的新型肽 ,可以自组装成具有有序纳米纤维结构的超分子水凝胶。纳米纤维与角膜上皮细胞具有良好的生物相容性,为增强基于游离肽的药物治疗眼部血管疾病(如 CNV 和其他与血管生成相关的疾病)的疗效提供了一种有前途的策略。
Nap-FFEEPCAIWF 纳米纤维为增强游离肽类药物治疗眼部血管疾病的疗效提供了一种替代方法。